Evidence map›Paper›PMID 33577591›Full record

ArticlePLoS computational biology2021

From heterogeneous healthcare data to disease-specific biomarker networks: A hierarchical Bayesian network approach.

Ann-Kristin Becker, Marcus Dörr, Stephan B Felix, Fabian Frost, Hans J Grabe, Markus M Lerch, Matthias Nauck, Uwe Völker, Henry Völzke, Lars Kaderali

Abstract read
In one paragraph

Article in PLoS computational biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Synthetic data generation with probabilistic Bayesian Networks.Mathematical biosciences and engineering : MBE · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ann-Kristin BeckerInstitute of Bioinformatics, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0003-1906-0583
Marcus DörrDepartment of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0001-7471-475X
Stephan B FelixDepartment of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0002-0744-091X
Fabian FrostDepartment of Internal Medicine A, University Medicine Greifswald, Greifswald, Germany.
Hans J GrabeDepartment of Psychiatry, University Medicine Greifswald, Greifswald, Germany.
Markus M LerchDepartment of Internal Medicine A, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0002-9643-8263
Matthias NauckInstitute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.
Uwe VölkerInterfaculty Institute of Genetics and Functional Genomics, Department of Functional Genomics, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0002-5689-3448
Henry VölzkeInstitute of Community Medicine, SHIP/KEF, University Medicine Greifswald, Greifswald, Germany.
Lars KaderaliInstitute of Bioinformatics, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0002-2359-2294

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, we introduce an entirely data-driven and automated approach to reveal disease-associated biomarker and risk factor networks from heterogeneous and high-dimensional healthcare data. Our workflow is based on Bayesian networks, which are a popular tool for analyzing the interplay of biomarkers. Usually, data require extensive manual preprocessing and dimension reduction to allow for effective learning of Bayesian networks. For heterogeneous data, this preprocessing is hard to automatize and typically requires domain-specific prior knowledge. We here combine Bayesian network learning with hierarchical variable clustering in order to detect groups of similar features and learn interactions between them entirely automated. We present an optimization algorithm for the adaptive refinement of such group Bayesian networks to account for a specific target variable, like a disease. The combination of Bayesian networks, clustering, and refinement yields low-dimensional but disease-specific interaction networks. These networks provide easily interpretable, yet accurate models of biomarker interdependencies. We test our method extensively on simulated data, as well as on data from the Study of Health in Pomerania (SHIP-TREND), and demonstrate its effectiveness using non-alcoholic fatty liver disease and hypertension as examples. We show that the group network models outperform available biomarker scores, while at the same time, they provide an easily interpretable interaction network.

Indexed as

AlgorithmsBayes TheoremBiomarkersCluster AnalysisComputational BiologyComputer SimulationDelivery of Health CareDiseaseGene Regulatory NetworksHumansHypertensionMedical InformaticsNormal DistributionPattern Recognition, AutomatedReproducibility of ResultsWineBiomarkers

Identifiers

PMID33577591
PMCPMC7906470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.